Integer Holdings Co. (ITGR) Trading Down 3%
Integer Holdings Co. (NASDAQ:ITGR)’s share price fell 3% during trading on Wednesday . The company traded as low as $22.65 and last traded at $22.82, with a volume of 78,899 shares changing hands. The stock had previously closed at $23.52.
A number of brokerages recently commented on ITGR. Zacks Investment Research cut Integer Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 2nd. TheStreet cut Integer Holdings from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Finally, Sterne Agee CRT reiterated a “buy” rating on shares of Integer Holdings in a research note on Monday, May 16th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $57.00.
The company’s market capitalization is $698.26 million. The stock’s 50-day moving average is $0.00 and its 200 day moving average is $0.00.
Integer Holdings (NASDAQ:ITGR) last released its earnings results on Thursday, July 28th. The company reported $0.56 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.70 by $0.14. The company earned $348.38 million during the quarter, compared to analysts’ expectations of $356.72 million. The company’s revenue was up 99.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.73 EPS. On average, equities analysts expect that Integer Holdings Co. will post $2.64 earnings per share for the current fiscal year.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.